M&A Deal Summary |
|
---|---|
Date | 2012-12-21 |
Target | Blue Star Group |
Sector | Business Services |
Buyer(s) | Mercury Capital Pty. |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2010 |
PE ASSETS | 400M AUD |
Size | Middle-Market |
Type | Sector Agnostic |
Mercury Capital is a private equity group focused on investing in established private businesses operating in Australia and New Zealand. Mercury looks to acquire controlling positions for a variety of situations, including succession plannings, expansion financings, recapitalizations, as well as partnering with existing management or owners to help drive growth. Mercury raised it's debut fund in 2010.
DEAL STATS | # |
---|---|
Overall | 1 of 7 |
Sector (Business Services) | 1 of 2 |
Type (Buyout (LBO, MBO, MBI)) | 1 of 2 |
Country (New Zealand) | 1 of 2 |
Year (2012) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-05-06 |
Novotech
Sydney, Australia Novotech is a full-service contract research organization (CRO). Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region. Novotech was founded in 1997 and is based in Sydney, Australia. |
Buy | - |